# Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Source: https://onco.cc/trials/nct06561048/  
OnCo record `nct06561048` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial testing Soquelitinib in peripheral T-cell lymphomas, now recruiting.

## Summary

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma is a phase 3 interventional study registered as NCT06561048, led by Corvus Pharmaceuticals, and recruiting on the registry. Official title: A Phase 3, Randomised, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma. Planned enrolment is 150 participants (estimated). The study started in 2024-10-02 and primary completion is expected in 2027-11. No results have been posted on ClinicalTrials.gov.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-11
- Tags: ctgov-ingest
- Registry id: NCT06561048
- Phase: 3
- Setting: A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Sponsor: Corvus Pharmaceuticals
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT06561048: https://clinicaltrials.gov/study/NCT06561048

## Connected records

- cancers: [Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma)](https://onco.cc/cancers/peripheral-t-cell-lymphoma/)
- drugs: [Soquelitinib](https://onco.cc/drugs/soquelitinib/)
- companies: [Corvus Pharmaceuticals](https://onco.cc/companies/corvus-pharmaceuticals/)

---
JSON: https://onco.cc/api/v1/entities/nct06561048.json